Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
28.89
+0.06 (0.21%)
At close: Nov 13, 2026, 4:00 PM EST
28.91
+0.02 (0.07%)
After-hours: Nov 13, 2026, 7:59 PM EST

Pfizer Revenue

Pfizer had revenue of $16.58B in the quarter ending September 27, 2026, a decrease of -0.43%. This brings the company's total for the last twelve months to $63.63B, up 1.34% year-over-year. In the year 2025, Pfizer had annual revenue of $62.58B, down -1.65%. That makes Pfizer the 193rd largest company in the world by revenue and 79th in the United States.

Revenue (ttm)
$63.63B
Revenue Growth
+1.34%
P/S Ratio
2.59
Revenue / Employee
$848,320
Employees
75,000
Market Cap
164.67B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Primary Care 26.82B 42.9%
  • Specialty Care 17.55B 28.1%
  • Oncology 16.83B 26.9%
  • Business Innovation (Pfizer CentreOne) 1.34B 2.1%

By Geography

Chart
  • United States 37.08B 59.2%
  • Developed Markets 16.19B 25.9%
  • Emerging Markets 9.31B 14.9%
Fiscal year ended Dec 31, 2025 See the full Pfizer breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202562.58B-1.05B-1.65%
Dec 31, 202463.63B4.07B6.84%
Dec 31, 202359.55B-41.62B-41.14%
Dec 31, 2022101.18B19.89B24.46%
Dec 31, 202181.29B39.64B95.16%
Dec 31, 202041.65B746.00M1.82%
Dec 31, 201940.91B80.00M0.20%
Dec 31, 201840.83B-11.72B-22.31%
Dec 31, 201752.55B-278.00M-0.53%
Dec 31, 201652.82B3.97B8.13%
Dec 31, 201548.85B-754.00M-1.52%
Dec 31, 201449.61B-1.98B-3.84%
Dec 31, 201351.58B-3.07B-5.62%
Dec 31, 201254.66B-6.38B-10.45%
Dec 31, 201161.04B-4.13B-6.34%
Dec 31, 201065.17B15.90B32.26%
Dec 31, 200949.27B973.00M2.01%
Dec 31, 200848.30B-122.00M-0.25%
Dec 31, 200748.42B47.00M0.10%
Dec 31, 200648.37B966.00M2.04%
Dec 31, 200547.41B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson99.34B
Merck & Co.67.38B
AbbVie66.01B
AstraZeneca62.38B
Sanofi57.89B
Novartis AG57.36B
Novo Nordisk50.70B
Bristol-Myers Squibb Company50.03B
Revenue Rankings